EVALUATION OF THERAPEUTIC EFFECT ON CIRRHOSIS OF EXTRACT FROM Helicteres hirsuta Lour. ON EXPERIMENTAL ANIMALS

Đắc Thăng Hoàng1, , Thị Thu Hiền Trương1, Minh Thanh Bùi1, Thái Dương Nguyễn 2, Hoàng Lê Tuấn Anh3
1 Học viện Quân y
2 Công ty TNHH Novopharm
3 Viện Hàn lâm Khoa học và Công nghệ Việt Nam

Main Article Content

Abstract

Objectives: Evaluate the therapeutic effect on cirrhosis of methanol extract (HHM) and water extract (HHW) from the aerial part of the Helicteres hirsuta L. Methods: Wistar rats were experimentally induced with liver cirrhosis using CCl₄ according to the model of Gao et al over 12 weeks. After the induction of cirrhosis, experimental animals were divided into six groups: Groups 1, 2, and 3 received distilled water 10 ml/kg/day; group 1 (control group): no cirrhosis induction; group 2: CCl4 injection was discontinued;  group 3: CCl4 injection was continued; group 4 (silymarin control) received oral silymarin at 0,2g/kg/day; group 5 (HHW): received oral HHW at 1,34g/kg/day; group 6 (HHM): received oral HHM at 1,3g/kg/day (CCl₄ injection was discontinued in groups 4, 5, and 6). The treatment phase lasted for 12 weeks. Results: The groups of rats received HHM extract (1,34 g/kg) and HHW extract (1,3 g/kg) showed alleviated liver dysfunction symptoms, prolonged survival time, and a significant reduction in the area of fibrotic bands in liver histology (15.14 ± 3.65% with HHW and 15.11 ± 4.38% with HHM) compared to the hepatotoxic control group (23.07 ± 5.41% and 24.78 ± 5.45%, p<0.01 and p<0.001). Conclusion: The HHW and HHM extracts lessen the severity of liver cirrhosis and prolong the survival time in experimental animals.

Article Details

References

1. Zamani M, Alizadeh-Tabari S, Ajmera V, Singh S, Murad MH, Loomba R. Global prevalence of advanced liver fibrosis and cirrhosis in the general population: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2025 Jun; 23(7):1123-1134.
2. Tsai FJ, Yang PY, Chen CJ, Li JP, Li TM, Chiou JS, Cheng CF, Chuang PH, Lin TH, Liao CC, Huang SM, Ban B, Liang WM, Lin YJ. Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan. BMC Complement Med Ther. 2020 Jul 14; 20(1):221.
3. Nguyễn Hữu Duyên, Lê Thanh Phước. Khảo sát thành phần hóa học và hoạt tính gây độc tế bào Hep-G2 của cây An xoa (Helicteres hirsuta L.). Tạp chí Khoa học Trường Đại học Cần Thơ. 2016; 47(4):93-97.
4. Dien PH. Cytotoxic constituents from aerial parts of Helicteres Hirsuta Plant, collected in Binh Phuoc Province. Hue University Journal of Science: Natural Science. 2018; 127(1A):111-117.
5. Gao J, Qin XJ, Jiang H, et al. Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry. Experimental and Therapeutic Medicine. 2017; 14(2):1496-1504.
6. Muriel P, Moreno MG, Hernández Mdel C, Chávez E, Alcantar LK. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. Basic Clin Pharmacol Toxicol. 2005; 96(5):375-380
7. Sharma P. Value of liver function tests in Cirrhosis. J Clin Exp Hepatol. 2022 May-Jun; 12(3):948-964.
8. Clichici S, Olteanu D, Filip A, Nagy AL, Oros A, Mircea PA. Beneficial effects of silymarin after the discontinuation of CCl4-induced liver fibrosis. Journal of Medicinal Food. 2016; 19(8):789-797.
9. Clichici S, Olteanu D, Nagy AL, Oros A, Filip A, Mircea PA. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats. Journal of Medicinal Food. 2015; 18(3):290-298.